Country for PR: United Kingdom
Contributor: PR Newswire Europe
Friday, February 19 2021 - 17:00
AsiaNet
Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease
LAUSANNE, Switzerland, Feb. 19, 2021 /PRNewswire-AsiaNet/ --

- Although essential for public health, new online survey findings show that 
people with self-reported rosacea* may be experiencing worsening of symptoms 
due to mask wearing, further increasing the daily burden for people living with 
this chronic skin disease
- Despite worsening of signs and symptoms, only a third (33%) of respondents 
have visited a healthcare provider (HCP) in person since the pandemic began

The COVID-19 pandemic has made mask wearing commonplace in many parts of the 
world, but for those suffering with facial skin disease, this can bring 
additional challenges. A recent survey conducted by Galderma suggests that the 
pandemic may impact rosacea patients, from worsening of signs and symptoms 
related to mask wearing, to reduced HCP consultations.[1] 

Although essential for public health, findings from the new online survey 
involving 220 respondents* from Canada and Germany reveal that almost two 
thirds (63%) are experiencing worsening of their symptoms related to mask 
wearing, including redness (75%), pimples and/or pustules (72%) and more 
flare-ups (53%).[1]

A recent independent clinical study in Italy, investigating the impact of mask 
wearing in rosacea and acne vulgaris patients, also found that prolonged use of 
face masks increases disease severity and significantly impacts the quality of 
life of rosacea and acne patients.[2]

Despite worsening of symptoms, over 1 in 2 (52%) people surveyed* admitted 
using mask wearing as a way to hide their disease, and 40% are not going out as 
often in order to avoid wearing a mask. The survey also revealed that almost a 
third (30%) are spending more time on their skincare routine during the 
pandemic. 

Additionally, nearly half (48%) have changed how they manage their disease 
since mask wearing, with 51% trying a non-prescription product and only 27% 
having been prescribed a new treatment by a HCP.[1]

Aliene Noda, Global Medical Franchise Lead Rosacea and Onco-Dermatology 
Prescription GBU, Galderma, comments on these findings: "With just a third of 
rosacea sufferers surveyed booking an appointment with their HCP during the 
pandemic, there is a huge cause for concern. Our survey suggests that more 
patients may be self-treating which could mean they are using products that are 
not specifically tailored for their skin disease and this could, ultimately, do 
more harm than good."

Prof. Dr Jerry Tan, Adjunct Professor, Western University, Ontario, Canada, 
says: "During the current pandemic, self-medication and inadequate use of 
prescribed rosacea treatments are concerning. Many rosacea sufferers are hiding 
their rosacea under a mask to reduce embarrassment. This could however also be 
worsening their rosacea. If you are suffering from rosacea, do not be afraid to 
book an appointment with your HCP via phone, video or in-person if possible. It 
is important to adhere to prescribed treatments and seek professional support 
if you are experiencing worsening of signs and symptoms because of mask 
wearing." 

The survey shows that only a third (33%) of respondents have visited their HCP 
in person since the pandemic began, with only 8% having a video consultation. 
Of those who have not booked an appointment, 47% stated they have not wanted to 
book an appointment, whilst 21% have been unable to book one.[1]  
       
*Based on a self-administered survey of www.FaceUpToRosacea.com and 
www.stelldichdeinerrosacea.de email subscribers during December 2020 – January 
2021. 87% of whom state that they have a rosacea diagnosis from a healthcare 
provider. 13% believe that they have rosacea but are not yet diagnosed

References:
1.  Data on file. Online survey of faceuptorosacea.com and 
stelldichdeinerrosacea.de https://www.stelldichdeinerrosacea.de/email 
subscribers (220 respondents from Canada and Germany)
2.  Damiani G, et al. Dermatol Ther. 2021 Feb. DOI: 10.1111/dth.14848. [Epub 
ahead of print].

About rosacea
Rosacea is a common inflammatory skin disease that presents variable clinical 
characteristics, of which the most common are flushing, persistent erythema, 
and inflammatory lesions. It mainly affects the central areas of the face, such 
as the cheeks and nose. The disease can affect both adult men and women, 
usually after the age of 30. Additionally, symptoms such as stinging, burning 
and increased sensitivity of the skin are common. The eyes are often affected, 
and might present as red, dry or itchy.

Although the cause of the disease is still under debate, various trigger 
factors are known, including spicy foods, alcohol, emotional stress, 
sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites, 
can also be found in the skin in an elevated quantity in people with rosacea.

Rosacea may worsen over time if left untreated. People that suspect they suffer 
from rosacea should visit their dermatologist or healthcare provider for 
diagnosis and discuss what treatment is right for them. Because rosacea is a 
highly visible disease, it is known to cause embarrassment and anxiety in some 
patients, which in turn may cause frustration and have a negative impact on 
their social life.

About Galderma
Galderma, the world's largest independent global dermatology company, was 
created in 1981 and is now present in over 100 countries with an extensive 
product portfolio of prescription medicines, aesthetic solutions and consumer 
care products. The company partners with health care practitioners around the 
world to meet the skin health needs of people throughout their lifetime. 
Galderma is a leader in research and development of scientifically-defined and 
medically-proven solutions for the skin. For more information, please visit 
www.galderma.com.

(C) 2021 Galderma S.A. All Right Reserved. All trademarks are the property of 
their respective owners

Source: Galderma